Home » Mexico Aims to Become a Global Leader in the Regulation of Biologic, Biosimilar Medicines
Mexico Aims to Become a Global Leader in the Regulation of Biologic, Biosimilar Medicines
The pharmaceutical market in Mexico remains the second most attractive in Latin America. The Economist Intelligence Unit projects a weak exchange rate for the Mexican peso in the forecast period, which will affect the value of the Mexican pharmaceutical market in U.S. dollar terms.
Business Review USA
Business Review USA
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May